Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
A selective portfolio of high quality healthcare businesses in truly innovative areas of science
As we seek to build companies in truly innovative areas in healthcare, our ultimate goal is to deliver transformational treatments to patients, enabling them to continue enjoying their lives
Syncona speaks to Achilles Therapeutics' clinical founder Charlie Swanton about his career, the advent of immunotherapy, and what he wants Achilles to achieve.